Tripti De Selected Research

Antimony

4/2012	Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
2/2012	Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.
6/2005	Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tripti De Research Topics

Disease

14	Visceral Leishmaniasis (Kala Azar) 01/2016 - 06/2005
9	Infections 12/2014 - 12/2007
3	Leishmaniasis 11/2014 - 04/2010
2	Disease Progression 01/2016 - 08/2012
1	Parasitic Diseases (Parasitic Disease) 02/2015
1	Hypersensitivity (Allergy) 01/2013
1	Inflammation (Inflammations) 01/2013
1	Necrosis 04/2012
1	Communicable Diseases (Infectious Diseases) 12/2007

Drug/Important Bio-Agent (IBA)

5	Peptide Hydrolases (Proteases)FDA Link 02/2015 - 01/2009
5	Interleukin-10 (Interleukin 10)IBA 12/2014 - 12/2007
4	Pharmaceutical PreparationsIBA 12/2014 - 12/2007
3	Serine Proteases (Serine Protease)IBA 01/2016 - 04/2010
3	AntimonyIBA 04/2012 - 06/2005
3	VaccinesIBA 08/2009 - 06/2005
3	AntigensIBA 08/2009 - 12/2007
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2016 - 11/2014
2	Interleukin-12 (IL 12)IBA 12/2014 - 12/2014
2	CytokinesIBA 01/2013 - 06/2005
2	GalactosyltransferasesIBA 08/2009 - 08/2009
2	Interleukin-4 (Interleukin 4)IBA 12/2007 - 06/2005
1	Aprotinin (Trasylol)FDA Link 12/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2014
1	Glycoproteins (Glycoprotein)IBA 12/2014
1	Lithium ChlorideIBA 12/2014
1	Galactose (Galactopyranose)FDA LinkGeneric 12/2014
1	InterleukinsIBA 12/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2013
1	asiaticosideIBA 04/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2012
1	gluconic acid (gluconate)FDA LinkGeneric 02/2012
1	SodiumIBA 02/2012
1	Amphotericin B (Amphotericin)FDA LinkGeneric 02/2012
1	LigandsIBA 01/2012
1	LipidsIBA 05/2011
1	Uridine Diphosphate (UDP)IBA 08/2009
1	AcetylglucosamineIBA 08/2009
1	Surface Antigens (Surface Antigen)IBA 06/2008
1	Immunodominant EpitopesIBA 12/2007
1	Interleukin-13IBA 12/2007
1	DNA (Deoxyribonucleic Acid)IBA 06/2005
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2005
1	Antigen-Antibody Complex (Immune Complex)IBA 06/2005

Therapy/Procedure

3	Therapeutics 12/2014 - 02/2012
2	Immunotherapy 01/2012 - 12/2007
1	Drug Therapy (Chemotherapy) 10/2013